SERAFINI MARTA

De Ponti, G., Santi, L., Dina, G., Pievani, A., Donsante, S., Riminucci, M., et al. (2025). Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I. MOLECULAR THERAPY. METHODS & CLINICAL DEVELOPMENT, 33(3 (11 September 2025)) [10.1016/j.omtm.2025.101544]. Dettaglio

Lisi-Vega, L., Pievani, A., García-Fernández, M., Forte, D., Williams, T., Serafini, M., et al. (2025). Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia. CELL REPORTS, 44(1) [10.1016/j.celrep.2024.115151]. Dettaglio

Pisani, I., Melita, G., de Souza, P., Galimberti, S., Savino, A., Sarno, J., et al. (2025). Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability. JOURNAL OF TRANSLATIONAL MEDICINE, 23(1) [10.1186/s12967-025-06416-3]. Dettaglio

Pievani, A., Biondi, M., Tettamanti, S., Biondi, A., Dotti, G., Serafini, M. (2024). CARs are sharpening their weapons. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 12(1) [10.1136/jitc-2023-008275]. Dettaglio

Fontana, D., Crespiatico, I., Zaghi, M., Mastini, C., D’Aliberti, D., Mauri, M., et al. (2024). First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis. Intervento presentato a: Forum nazionale sulla Medicina di Precisione. Il Modello HEAL ITALIA e il contributo della Ricerca al Sistema Sanitario del Futuro, Palermo, Italia. Dettaglio